Asia-Pacific Health & MedTech Innovation Opportunity
Confidential Expressions of Interest – Sophisticated & Institutional Investors Only
Be part of the next generation of health and deep-tech innovation across the Asia-Pacific.
This opportunity provides proprietary access to a highly curated pipeline of medtech, biotech and healthtech ventures, underpinned by an exclusive partnership with a leading healthcare innovator in the region. Combining venture development with venture capital, it targets scalable solutions at the forefront of global wellbeing.
With a pan-APAC footprint across Australia, Singapore and Japan, and a wide network of clinical, research and commercial collaborators, this platform is positioned to benefit from a region forecast to drive over 40% of global growth in healthcare spending over the next decade.
Key features include:
- Exclusive deal flow via a premier healthtech accelerator with a proven startup launch track record
- Focus on deep technology applied to health, supported by domain experts and industry partners
- Institutional-grade governance and an experienced team, aiming to deliver above-benchmark returns with measurable impact
Available strictly to:
- Sophisticated Investors (Australia) under the Corporations Act
- Accredited / Institutional Investors (International)
If you are an active wholesale investor seeking meaningful exposure to health innovation in Asia-Pacific, we invite your confidential Expression of Interest. Submit an EOI to learn more.
Disclaimer: Eden Exchange Pty Ltd (ACN 152 787 212) is a Corporate Authorised Representative (AR No. 001310143) of Melbourne Venture Securities Pty Ltd (ACN 106 186 389), AFSL No. 277465. This information is general in nature and intended solely for wholesale clients as defined under the Corporations Act 2001 (Cth) or accredited/institutional investors under MAS regulations. It does not constitute financial advice or an offer to retail clients.
